SCHEMBL25910702

SCHEMBL25910702

CNC(=O)Nc1cc(Oc2cnc3nc(-c4cnc(NC(C)C)n(C)c4=O)ccc3c2)ccn1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 4/20 0.48
▸ PDGFRB P09619 4/20 0.48
▸ PDGFRA P16234 3/20 0.48
▸ LCK P06239 2/20 0.48
▸ KIT P10721 2/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ FLT3 P36888 1/20 0.48
▸ PTK6 Q13882 1/20 0.48
▸ GCK P35557 4/20 0.45
▸ P2RX3 P56373 2/20 0.41
▸ BRAF P15056 9/20 0.38
▸ RIOK2 Q9BVS4 1/20 0.36
▸ FYN P06241 1/20 0.34
▸ SRC P12931 1/20 0.34
▸ FLT1 P17948 1/20 0.34
▸ FLT4 P35916 1/20 0.34
▸ KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25910177 0.92 PDGFRB (0.51) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25910698 0.91 CSF1R (0.48) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25910931 0.90 GCK (0.44) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25910403 0.89 CSF1R (0.48) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25912627 0.88 PDGFRB (0.46) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25910168 0.87 CSF1R (0.54) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25910804 0.85 BRAF (0.44) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25910935 0.84 PDGFRB (0.39) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25319458 0.84 CSF1R (0.52) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25910178 0.84 CSF1R (0.52) CSF1RPDGFRBPDGFRALCKKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback